Primary surgery or neoadjuvant chemotherapy in ovarian cancer: What is the value of comparing apples with oranges?

被引：26

作者：

Vergote, Ignace ^{[1
]}

Leunen, Karin ^{[1
]}

Amant, Frederic ^{[1
]}

机构：

[1] Katholieke Univ Leuven, Univ Hosp, Div Gynaecol Oncol, Dept Obstet & Gynaecol,European Union, B-3000 Louvain, Belgium

来源：

GYNECOLOGIC ONCOLOGY | 2012年 / 124卷 / 01期

关键词：

CARCINOMA;

D O I：

10.1016/j.ygyno.2011.11.010

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1 / 2

页数：2

共 10 条

[1] Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: A meta-analysis [J].

Bristow, Robert E. ;

Chi, Dennis S. .

GYNECOLOGIC ONCOLOGY, 2006, 103 (03) :1070-1076

[2] An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT) [J].

Chi, Dennis S. ;

Musa, Fernanda ;

Dao, Fanny ;

Zivanovic, Oliver ;

Sonoda, Yukio ;

Leitao, Mario M. ;

Levine, Douglas A. ;

Gardner, Ginger J. ;

Abu-Rustum, Nadeem R. ;

Barakat, Richard R. .

GYNECOLOGIC ONCOLOGY, 2012, 124 (01) :10-14

[3] Does Neoadjuvant Chemotherapy Increase Optimal Cytoreduction Rate in Advanced Ovarian Cancer? Meta-Analysis of 21 Studies [J].

Kang, Sokbom ;

Nam, Byung-Ho .

ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (08) :2315-2320

[4]

Onda T, 1998, CANCER, V83, P1555, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1555::AID-CNCR10>3.3.CO

[5]

2-I

[6] 2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on Clinical Trials in Ovarian Cancer Report From the Fourth Ovarian Cancer Consensus Conference [J].

Stuart, Gavin C. E. ;

Kitchener, Henry ;

Bacon, Monica ;

duBois, Andreas ;

Friedlander, Michael ;

Ledermann, Jonathan ;

Marth, Christian ;

Thigpen, Tate ;

Trimble, Edward .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (04) :750-755

[7] Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: A retrospective analysis of 285 patients [J].

Vergote, I ;

De Wever, I ;

Tjalma, W ;

Van Gramberen, M ;

Decloedt, J ;

van Dam, P .

GYNECOLOGIC ONCOLOGY, 1998, 71 (03) :431-436

[8] Neoadjuvant Chemotherapy Is the Better Treatment Option in Some Patients With Stage IIIc to IV Ovarian Cancer [J].

Vergote, Ignace ;

Trope, Claes G. ;

Amant, Frederic ;

Ehlen, Tom ;

Reed, Nick S. ;

Casado, Antonio .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (31) :4076-4078

[9] Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer [J].

Vergote, Ignace ;

Amant, Frederic ;

Kristensen, Gunnar ;

Ehlen, Tom ;

Reed, Nick S. ;

Casado, Antonio .

EUROPEAN JOURNAL OF CANCER, 2011, 47 :S88-S92

[10] Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer [J].

Vergote, Ignace ;

Trope, Claes G. ;

Amant, Frederic ;

Kristensen, Gunnar B. ;

Ehlen, Tom ;

Johnson, Nick ;

Verheijen, Rene H. M. ;

van der Burg, Maria E. L. ;

Lacave, Angel J. ;

Panici, Pierluigi Benedetti ;

Kenter, Gemma G. ;

Casado, Antonio ;

Mendiola, Cesar ;

Coens, Corneel ;

Verleye, Leen ;

Stuart, Gavin C. E. ;

Pecorelli, Sergio ;

Reed, Nick S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (10) :943-953

← 1 →